SUPN logo

Supernus Pharmaceuticals (SUPN) Shareholders equity

annual shareholders equity:

$1.04B+$114.22M(+12.39%)
December 31, 2024

Summary

  • As of today (May 29, 2025), SUPN annual stockholders equity is $1.04 billion, with the most recent change of +$114.22 million (+12.39%) on December 31, 2024.
  • During the last 3 years, SUPN annual shareholders equity has risen by +$219.88 million (+26.95%).
  • SUPN annual shareholders equity is now at all-time high.

Performance

SUPN Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNbalance sheet metrics

quarterly shareholders equity:

$1.03B-$5.03M(-0.49%)
March 31, 2025

Summary

  • As of today (May 29, 2025), SUPN quarterly stockholders equity is $1.03 billion, with the most recent change of -$5.03 million (-0.49%) on March 31, 2025.
  • Over the past year, SUPN quarterly shareholders equity has increased by +$101.54 million (+10.93%).
  • SUPN quarterly shareholders equity is now -0.49% below its all-time high of $1.04 billion, reached on December 31, 2024.

Performance

SUPN quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

SUPN Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+12.4%+10.9%
3 y3 years+26.9%+24.4%
5 y5 years+74.0%+68.0%

SUPN Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+26.9%-0.5%+24.4%
5 y5-yearat high+74.0%-0.5%+68.0%
alltimeall timeat high+2436.9%-0.5%+1521.2%

SUPN Shareholders equity History

DateAnnualQuarterly
Mar 2025
-
$1.03B(-0.5%)
Dec 2024
$1.04B(+12.4%)
$1.04B(+2.8%)
Sep 2024
-
$1.01B(+5.2%)
Jun 2024
-
$957.45M(+3.0%)
Mar 2024
-
$929.17M(+0.8%)
Dec 2023
$921.52M(+4.0%)
$921.52M(+1.0%)
Sep 2023
-
$912.19M(-0.8%)
Jun 2023
-
$919.91M(+0.9%)
Mar 2023
-
$912.15M(+2.9%)
Dec 2022
$886.20M(+8.6%)
$886.20M(+3.9%)
Sep 2022
-
$852.80M(+1.4%)
Jun 2022
-
$841.43M(+1.6%)
Mar 2022
-
$828.45M(+1.5%)
Dec 2021
$815.85M(+9.5%)
$815.85M(+0.7%)
Sep 2021
-
$810.47M(+3.2%)
Jun 2021
-
$785.58M(+4.1%)
Mar 2021
-
$754.44M(+1.3%)
Dec 2020
$744.86M(+25.1%)
$744.86M(+5.1%)
Sep 2020
-
$708.88M(+6.4%)
Jun 2020
-
$665.97M(+8.6%)
Mar 2020
-
$613.38M(+3.0%)
Dec 2019
$595.43M(+31.4%)
$595.43M(+6.8%)
Sep 2019
-
$557.26M(+6.6%)
Jun 2019
-
$522.90M(+8.9%)
Mar 2019
-
$480.02M(+6.0%)
Dec 2018
$453.02M(+69.4%)
$453.02M(+7.4%)
Sep 2018
-
$421.94M(+8.1%)
Jun 2018
-
$390.49M(+11.0%)
Mar 2018
-
$351.87M(+31.5%)
DateAnnualQuarterly
Dec 2017
$267.48M(+39.5%)
$267.48M(+6.3%)
Sep 2017
-
$251.66M(+9.7%)
Jun 2017
-
$229.40M(+11.3%)
Mar 2017
-
$206.06M(+7.5%)
Dec 2016
$191.75M(+117.9%)
$191.75M(+10.6%)
Sep 2016
-
$173.37M(+22.9%)
Jun 2016
-
$141.02M(+10.1%)
Mar 2016
-
$128.14M(+45.6%)
Dec 2015
$88.01M(+116.2%)
$88.01M(-19.6%)
Sep 2015
-
$109.44M(+6.9%)
Jun 2015
-
$102.36M(+8.2%)
Mar 2015
-
$94.58M(+132.4%)
Dec 2014
$40.70M(+21.6%)
$40.70M(-38.4%)
Sep 2014
-
$66.12M(+98.1%)
Jun 2014
-
$33.37M(+15.0%)
Mar 2014
-
$29.01M(-13.3%)
Dec 2013
$33.46M(-41.9%)
$33.46M(+168.7%)
Sep 2013
-
$12.45M(-65.3%)
Jun 2013
-
$35.89M(-13.0%)
Mar 2013
-
$41.27M(-28.3%)
Dec 2012
$57.57M(+509.7%)
$57.57M(+133.7%)
Sep 2012
-
$24.63M(-35.1%)
Jun 2012
-
$37.98M(>+9900.0%)
Mar 2012
-
$274.00K(-97.1%)
Dec 2011
$9.44M(-121.3%)
$9.44M(-113.0%)
Sep 2011
-
-$72.52M(+63.6%)
Dec 2010
-$44.32M(+619.9%)
-$44.32M(+23.4%)
Sep 2010
-
-$35.92M(+483.4%)
Dec 2009
-$6.16M(-8.8%)
-$6.16M
Dec 2008
-$6.75M
-

FAQ

  • What is Supernus Pharmaceuticals annual stockholders equity?
  • What is the all time high annual shareholders equity for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals annual shareholders equity year-on-year change?
  • What is Supernus Pharmaceuticals quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals quarterly shareholders equity year-on-year change?

What is Supernus Pharmaceuticals annual stockholders equity?

The current annual shareholders equity of SUPN is $1.04B

What is the all time high annual shareholders equity for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high annual stockholders equity is $1.04B

What is Supernus Pharmaceuticals annual shareholders equity year-on-year change?

Over the past year, SUPN annual stockholders equity has changed by +$114.22M (+12.39%)

What is Supernus Pharmaceuticals quarterly stockholders equity?

The current quarterly shareholders equity of SUPN is $1.03B

What is the all time high quarterly shareholders equity for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high quarterly stockholders equity is $1.04B

What is Supernus Pharmaceuticals quarterly shareholders equity year-on-year change?

Over the past year, SUPN quarterly stockholders equity has changed by +$101.54M (+10.93%)
On this page